Drug or treatment

Olverembatinib clinical trials

• 12Clinical trials
• 19Countries

Newest trials

All recruiting trials (12)

• How olverembatinib is processed in people with liver impairment

  This test gives a single 20 mg dose of olverembatinib to people with different levels of chronic liver impairment and matched healthy volunteers to see how the drug is absorbed, distributed, metabolized, and cleared.

  Recruiting Phase 1 Ascentage Pharma Group Inc. · Suzhou, Jiangsu · NCT07282093

• ThisCART19A plus Olverembatinib for newly diagnosed Ph+ ALL

  A one-arm study tests whether ThisCART19A plus Olverembatinib can safely and effectively treat adults with newly diagnosed Philadelphia chromosome–positive ALL.

  Recruiting at 2 sites Early Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 1 other locations · NCT07074496

• Olverembatinib monotherapy for adults with newly diagnosed chronic-phase CML

  We are testing whether olverembatinib can control disease and produce deep molecular responses in adults newly diagnosed with chronic-phase CML.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT06817720

• Combination treatment for blast phase CML using olverembatinib, venetoclax, and azacitidine

  This study is testing a new combination of three medications to see if it can help people aged 15 and older with blast phase chronic myeloid leukemia feel better and improve their treatment options.

  Recruiting Phase 1/2 Institute of Hematology & Blood Diseases Hospital, China · Tianjin, Tianjin Municipality · NCT06757855

• Combining Venetoclax, Olverembatinib, and Prednisone for treating Ph+ B-ALL

  This study is testing a new combination of three drugs to see if it can help adults with a specific type of aggressive leukemia feel better and live longer.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06754267

• Olverembatinib for treating SDH-deficient GIST

  This study is testing if a new medication called olverembatinib can help people with a specific type of gastrointestinal tumor feel better after they’ve already tried one other treatment.

  Recruiting Phase 3 Ascentage Pharma Group Inc. · Guangzhou, Guangdong · NCT06640361

• Treatment of Chronic Myeloid Leukemia with Olverembatinib

  This study is testing if a new drug called olverembatinib can help people with chronic myeloid leukemia feel better compared to an existing treatment, and it looks at two groups of patients based on a specific genetic mutation.

  Recruiting at 135 sites Phase 3 Ascentage Pharma Group Inc. · Birmingham, Alabama and 162 other locations · NCT06423911

• Combination therapy for advanced chronic myeloid leukemia and acute myeloid leukemia

  This study is testing a new combination of three drugs to see if it can help people with advanced chronic myeloid leukemia and a specific type of acute myeloid leukemia feel better and live longer.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT06401603

• Treatment for newly diagnosed Philadelphia Chromosome-positive acute lymphoblastic leukemia

  This study is testing a new combination treatment for people with newly diagnosed Philadelphia Chromosome-positive acute lymphoblastic leukemia to see if it can help them achieve complete remission and improve their chances of survival.

  Recruiting Phase 2 Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT06220487

• Evaluating Olverembatinib for Newly Diagnosed Ph+ ALL

  This study is testing if a new drug called Olverembatinib, used with chemotherapy, can help people with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia do better than the standard treatment with Imatinib and chemotherapy.

  Recruiting at 8 sites Phase 3 Ascentage Pharma Group Inc. · Birmingham, Alabama and 89 other locations · NCT06051409

• Treatment of FGFR1-rearranged neoplasms with Olverembatinib

  This study is testing if a new drug called Olverembatinib can help people with rare blood cancers caused by FGFR1 changes get better and possibly prepare them for a stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05521204

• Olverembatinib plus APG-2575 for children with relapsed or refractory Philadelphia-positive ALL

  This study tests whether a combination of olverembatinib and APG-2575, with dexamethasone, is safe and potentially effective in children with relapsed or refractory Ph+ ALL who have already tried other TKIs.

  Recruiting Phase 1 Institute of Hematology & Blood Diseases Hospital, China · Hefei, Anhui and 3 other locations · NCT05495035

Quick answers

How many clinical trials of Olverembatinib are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 19 countries. The most sites are in China (9 trials), United States (4 trials), Australia (2 trials), France (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 3, Phase 3: 3, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →